Literature DB >> 11588999

Hippocampal lesions in the neuronal ceroid lipofuscinoses.

M Haltia1, R Herva, J Suopanki, M Baumann, J Tyynelä.   

Abstract

Epilepsy is a common manifestation in all childhood-onset forms of neuronal ceroid lipofuscinosis. In order to document hippocampal lesions and their relationship to epilepsy we studied autopsy specimens from the hippocampi of a series of patients with the infantile (CLN1), classic late infantile (CLN2), Finnish variant late infantile (CLN5), and juvenile (CLN3) neuronal ceroid-lipofuscinosis as well as Northern epilepsy (CLN8), using a battery of histological and immunocytochemical staining methods. Despite striking differences in the overall degree of neocortical neuronal storage and loss, these genetically heterogeneous forms of neuronal ceroid lipofuscinosis showed a common lesional pattern in the hippocampi: a relative sparing of the CA1 sector and severe involvement of the neighbouring CA2 sector, with intermediate degrees of involvement of the CA3 and CA4 sectors. These findings distinguish the hippocampal pathology associated with the neuronal ceroid lipofuscinoses from classical 'mesial temporal sclerosis' and show that the selective lesional pattern in the neuronal ceroid lipofuscinoses is not a secondary anoxic-ischaemic phenomenon. It is rather a consequence of the primary metabolic defects and may be directly involved in the causation of the epileptic discharges.

Entities:  

Mesh:

Year:  2001        PMID: 11588999     DOI: 10.1053/eipn.2000.0464

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  11 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorder.

Authors:  Rebecca C Ahrens-Nicklas; Luis Tecedor; Arron F Hall; Elena Lysenko; Akiva S Cohen; Beverly L Davidson; Eric D Marsh
Journal:  JCI Insight       Date:  2019-11-01

3.  A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera.

Authors:  Nancy Galvin; Carole Vogler; Beth Levy; Attila Kovacs; Megan Griffey; Mark S Sands
Journal:  Pediatr Dev Pathol       Date:  2007-05-23

Review 4.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

5.  Characterization of neurological disease progression in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Elizabeth J Meiman; Grace Robinson Kick; Cheryl A Jensen; Joan R Coates; Martin L Katz
Journal:  Dev Neurobiol       Date:  2022-04-28       Impact factor: 3.102

6.  The neuronal ceroid lipofuscinosis Cln8 gene expression is developmentally regulated in mouse brain and up-regulated in the hippocampal kindling model of epilepsy.

Authors:  Liina Lonka; Antti Aalto; Outi Kopra; Mervi Kuronen; Zaal Kokaia; Mart Saarma; Anna-Elina Lehesjoki
Journal:  BMC Neurosci       Date:  2005-04-13       Impact factor: 3.288

7.  Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons.

Authors:  Lotta Parviainen; Sybille Dihanich; Greg W Anderson; Andrew M Wong; Helen R Brooks; Rosella Abeti; Payam Rezaie; Giovanna Lalli; Simon Pope; Simon J Heales; Hannah M Mitchison; Brenda P Williams; Jonathan D Cooper
Journal:  Acta Neuropathol Commun       Date:  2017-10-17       Impact factor: 7.801

8.  Global Brain Transcriptome Analysis of a Tpp1 Neuronal Ceroid Lipofuscinoses Mouse Model.

Authors:  Miriam S Domowicz; Wen-Ching Chan; Patricia Claudio-Vázquez; Judith G Henry; Christopher B Ware; Jorge Andrade; Glyn Dawson; Nancy B Schwartz
Journal:  ASN Neuro       Date:  2019 Jan-Dec       Impact factor: 4.146

Review 9.  Progressive myoclonic epilepsy.

Authors:  Mary L Zupanc; Benjamin Legros
Journal:  Cerebellum       Date:  2004       Impact factor: 3.648

Review 10.  The CLN3 gene and protein: What we know.

Authors:  Myriam Mirza; Anna Vainshtein; Alberto DiRonza; Uma Chandrachud; Luke J Haslett; Michela Palmieri; Stephan Storch; Janos Groh; Niv Dobzinski; Gennaro Napolitano; Carolin Schmidtke; Danielle M Kerkovich
Journal:  Mol Genet Genomic Med       Date:  2019-09-30       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.